Research priorities to reduce the impact of COVID-19 in low- and middle-income countries.


Journal

Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780

Informations de publication

Date de publication:
2022
Historique:
entrez: 27 4 2022
pubmed: 28 4 2022
medline: 29 4 2022
Statut: epublish

Résumé

The COVID-19 pandemic has caused disruptions to the functioning of societies and their health systems. Prior to the pandemic, health systems in low- and middle-income countries (LMIC) were particularly stretched and vulnerable. The International Society of Global Health (ISoGH) sought to systematically identify priorities for health research that would have the potential to reduce the impact of the COVID-19 pandemic in LMICs. The Child Health and Nutrition Research Initiative (CHNRI) method was used to identify COVID-19-related research priorities. All ISoGH members were invited to participate. Seventy-nine experts in clinical, translational, and population research contributed 192 research questions for consideration. Fifty-two experts then scored those questions based on five pre-defined criteria that were selected for this exercise: 1) feasibility and answerability; 2) potential for burden reduction; 3) potential for a paradigm shift; 4) potential for translation and implementation; and 5) impact on equity. Among the top 10 research priorities, research questions related to vaccination were prominent: health care system access barriers to equitable uptake of COVID-19 vaccination (ranked 1st), determinants of vaccine hesitancy (4th), development and evaluation of effective interventions to decrease vaccine hesitancy (5th), and vaccination impacts on vulnerable population/s (6th). Health care delivery questions also ranked highly, including: effective strategies to manage COVID-19 globally and in LMICs (2nd) and integrating health care for COVID-19 with other essential health services in LMICs (3rd). Additionally, the assessment of COVID-19 patients' needs in rural areas of LMICs was ranked 7th, and studying the leading socioeconomic determinants and consequences of the COVID-19 pandemic in LMICs using multi-faceted approaches was ranked 8th. The remaining questions in the top 10 were: clarifying paediatric case-fatality rates (CFR) in LMICs and identifying effective strategies for community engagement against COVID-19 in different LMIC contexts. Health policy and systems research to inform COVID-19 vaccine uptake and equitable access to care are urgently needed, especially for rural, vulnerable, and/or marginalised populations. This research should occur in parallel with studies that will identify approaches to minimise vaccine hesitancy and effectively integrate care for COVID-19 with other essential health services in LMICs. ISoGH calls on the funders of health research in LMICs to consider the urgency and priority of this research during the COVID-19 pandemic and support studies that could make a positive difference for the populations of LMICs.

Sections du résumé

Background UNASSIGNED
The COVID-19 pandemic has caused disruptions to the functioning of societies and their health systems. Prior to the pandemic, health systems in low- and middle-income countries (LMIC) were particularly stretched and vulnerable. The International Society of Global Health (ISoGH) sought to systematically identify priorities for health research that would have the potential to reduce the impact of the COVID-19 pandemic in LMICs.
Methods UNASSIGNED
The Child Health and Nutrition Research Initiative (CHNRI) method was used to identify COVID-19-related research priorities. All ISoGH members were invited to participate. Seventy-nine experts in clinical, translational, and population research contributed 192 research questions for consideration. Fifty-two experts then scored those questions based on five pre-defined criteria that were selected for this exercise: 1) feasibility and answerability; 2) potential for burden reduction; 3) potential for a paradigm shift; 4) potential for translation and implementation; and 5) impact on equity.
Results UNASSIGNED
Among the top 10 research priorities, research questions related to vaccination were prominent: health care system access barriers to equitable uptake of COVID-19 vaccination (ranked 1st), determinants of vaccine hesitancy (4th), development and evaluation of effective interventions to decrease vaccine hesitancy (5th), and vaccination impacts on vulnerable population/s (6th). Health care delivery questions also ranked highly, including: effective strategies to manage COVID-19 globally and in LMICs (2nd) and integrating health care for COVID-19 with other essential health services in LMICs (3rd). Additionally, the assessment of COVID-19 patients' needs in rural areas of LMICs was ranked 7th, and studying the leading socioeconomic determinants and consequences of the COVID-19 pandemic in LMICs using multi-faceted approaches was ranked 8th. The remaining questions in the top 10 were: clarifying paediatric case-fatality rates (CFR) in LMICs and identifying effective strategies for community engagement against COVID-19 in different LMIC contexts.
Interpretation UNASSIGNED
Health policy and systems research to inform COVID-19 vaccine uptake and equitable access to care are urgently needed, especially for rural, vulnerable, and/or marginalised populations. This research should occur in parallel with studies that will identify approaches to minimise vaccine hesitancy and effectively integrate care for COVID-19 with other essential health services in LMICs. ISoGH calls on the funders of health research in LMICs to consider the urgency and priority of this research during the COVID-19 pandemic and support studies that could make a positive difference for the populations of LMICs.

Identifiants

pubmed: 35475006
doi: 10.7189/jogh.12.09003
pii: jogh-12-09003
pmc: PMC9010705
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

09003

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2022 by the Journal of Global Health. All rights reserved.

Déclaration de conflit d'intérêts

Competing interests: Ana Marušić, Harry Campbell and Igor Rudan are the Co-Editors in Chief of the Journal of Global Health. To ensure that any possible conflict of interest relevant to the journal has been addressed, this article was reviewed according to best practice guidelines of international editorial organisations. The authors completed the ICMJE Unified Competing Interests Form (available upon request from the corresponding author) and declare no further conflicts of interest.

Références

J Glob Health. 2021 Nov 20;11:04071
pubmed: 34912548
Croat Med J. 2008 Dec;49(6):720-33
pubmed: 19090596
J Glob Health. 2016 Jun;6(1):010301
pubmed: 26401269
PLoS One. 2021 Sep 24;16(9):e0257516
pubmed: 34559827
J Glob Health. 2016 Jun;6(1):010503
pubmed: 27350874
J Glob Health. 2021 Nov 20;11:05027
pubmed: 34912550
J Glob Health. 2016 Jun;6(1):010507
pubmed: 26401271
J Glob Health. 2016 Jun;6(1):010303
pubmed: 27303649
J Glob Health. 2016 Jun;6(1):010501
pubmed: 27418959
Midwifery. 2021 Apr;95:102922
pubmed: 33515973
Lancet. 2021 Oct 2;398(10307):1212-1213
pubmed: 34600618
Am J Respir Crit Care Med. 2021 Feb 1;203(3):287-295
pubmed: 33522881
JAMA. 2014 Nov 12;312(18):1859-60
pubmed: 25285459
BMJ Glob Health. 2020 Jul;5(7):
pubmed: 32727843
J Glob Health. 2016 Jun;6(1):010302
pubmed: 27350870
Vaccines (Basel). 2019 Oct 18;7(4):
pubmed: 31635270
Wellcome Open Res. 2020 Sep 8;5:209
pubmed: 33117894
Lancet Glob Health. 2022 Apr;10(4):e570-e573
pubmed: 35303466
J Glob Health. 2016 Jun;6(1):010502
pubmed: 27350873
Nat Med. 2021 Aug;27(8):1385-1394
pubmed: 34272499
Vaccine. 2021 Oct 22;39(44):6539-6544
pubmed: 34598823
BMJ Open. 2021 Oct 27;11(10):e052135
pubmed: 34706957
Lancet. 2020 Aug 8;396(10248):375
pubmed: 32682490
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
J Glob Health. 2021 Oct 09;11:15003
pubmed: 34737870
Expert Rev Vaccines. 2022 Jan;21(1):25-36
pubmed: 34758678
PLoS One. 2021 Aug 12;16(8):e0256099
pubmed: 34383861
PLoS One. 2021 Nov 29;16(11):e0260672
pubmed: 34843594
J Glob Health. 2017 Jun;7(1):011004
pubmed: 28685049
AAS Open Res. 2020 Nov 24;3:56
pubmed: 33709054
Lancet Respir Med. 2021 Dec;9(12):1467-1478
pubmed: 34416191

Auteurs

Ozren Polašek (O)

Department of Public Health, University of Split School of Medicine, Split, Croatia.
Croatian Centre for Global Health, University of Split, Croatia.
Algebra University College, Zagreb, Croatia.

Kerri Wazny (K)

Children's Investment Fund Foundation, London, UK.

Davies Adeloye (D)

Centre for Global Health, Usher Institute, University of Edinburgh, UK.

Peige Song (P)

School of Public Health and Women's Hospital, Zhejiang University School of Medicine, China.

Kit Y Chan (KY)

Centre for Global Health, Usher Institute, University of Edinburgh, UK.

Danladi A Bojude (DA)

Gombe State University, Gombe, Nigeria.

Sajjad Ali (S)

Department of Medicine, Ziauddin Medical University, Karachi, Pakistan.

Sheri Bastien (S)

Norwegian University of Life Sciences, Ås, Norway.

Francisco Becerra-Posada (F)

Public Health Development Organization, El Paso, Texas, USA.

Florencia Borrescio-Higa (F)

Universidad Adolfo Ibañez, Santiago, Chile.

Sohaila Cheema (S)

Weill Cornell Medicine - Qatar, Doha, Qatar.

Darien A Cipta (DA)

Universitas Pelita Harapan, Jakarta, Indonesia.

Smiljana Cvjetković (S)

Faculty of Medicine, University of Belgrade, Serbia.

Lina D Castro (LD)

National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.

Bassey Ebenso (B)

Leeds Institute of Health Sciences, University of Leeds, UK.

Omolade Femi-Ajao (O)

Faculty of Biology, Medicine and Health, University of Manchester, UK.

Balasankar Ganesan (B)

Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong.

Anton Glasnović (A)

Croatian Institute for Brain Research, Zagreb University School of Medicine, Zagreb, Croatia.

Longtao He (L)

Southwestern University of Finance and Economics, Chengdu, China.

Jean M Heraud (JM)

Institut Pasteur de Dakar, Dakar, Senegal.

Chinonso Igwesi-Chidobe (C)

University of Nigeria, Enugu Campus, Nigeria.

Per O Iversen (PO)

Department of Nutrition, University of Oslo, Norway.

Bismeen Jadoon (B)

Egyptian Representative, Committee of Fellows of Obstetrics and Gynaecology, Oxford, UK, Royal Berkshire Hospital, NHS, UK.

Abdulkarim J Karim (AJ)

College of Veterinary Medicine, University of Baghdad, Iraq.

Johra Khan (J)

Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah, Saudi Arabia.

Raaj K Biswas (RK)

University of New South Wales, Sydney, Australia.

Giuseppe Lanza (G)

Oasi Research Institute-IRCCS, Troina, Italy.
University of Catania, Catania, Italy.

Shaun Wh Lee (SW)

Monash University Malaysia, Selangor, Malaysia.

You Li (Y)

School of Public Health, Nanjing Medical University, China.

Li-Lin Liang (LL)

National Yang Ming Chiao Tung University, Taipei, Taiwan.

Mat Lowe (M)

Society for the Study of Women's Health, Kanifing, The Gambia.

Mohammad M Islam (MM)

University of Dhaka, Dhaka, Bangladesh.

Ana Marušić (A)

Department of Research in Biomedicine and Health, University of Split School of Medicine, Split, Croatia.

Suleiman Mshelia (S)

Jos University Teaching Hospital, Nigeria.

Anthony M Manyara (AM)

University of Glasgow, Glasgow, UK.

Mila Nn Htay (MN)

Department of Community Medicine, Faculty of Medicine, Manipal University College Malaysia, Melaka, Malaysia.

Michelle Parisi (M)

Clemson University, South Carolina, USA.

Prince Peprah (P)

Social Policy Research Centre/Centre for Primary Health Care and Equity, University of New South Wales, Sydney, Australia.

Emma Sacks (E)

Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.

Kabiru O Akinyemi (KO)

Lagos State University, Ojo, Lagos, Nigeria.

Fariba Shahraki-Sanavi (F)

Zahedan University of Medical Sciences, Iran.

Konstantin Sharov (K)

Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Moscow, Russia.

Elena S Rotarou (ES)

Universidad San Sebastián, Santiago, Chile.

Srdjan Stankov (S)

Pasteur Institute Novi Sad, Novi Sad, Serbia.

Wenang Supriyatiningsih (W)

Children and Mother Health Movement Action, Yogyakarta, Indonesia.

Benjamin Ty Chan (BT)

Hong Kong Metropolitan University, Hong Kong.

Mark Tremblay (M)

CHEO Research Institute, Ottawa, Canada.

Dialechti Tsimpida (D)

Faculty of Biology, Medicine and Health, University of Manchester, UK.

Sandro Vento (S)

University of Puthisastra, Phnom Penh, Cambodia.

Josipa V Glasnović (JV)

Department of Hematology, Dubrava University Hospital, Zagreb, Croatia.

Liang Wang (L)

Xuzhou Medical University, Yuzhou, China.

Xin Wang (X)

School of Public Health, Nanjing Medical University, China.

Zhi X Ng (ZX)

School of Biosciences, Faculty of Science and Engineering, University of Nottingham Malaysia, Semenyih, Malaysia.

Jianrong Zhang (J)

University of Melbourne, Melbourne, Australia.

Yanfeng Zhang (Y)

Capital Institute of Pediatrics, Beijing, China.

Harry Campbell (H)

Centre for Global Health, Usher Institute, University of Edinburgh, UK.

Mickey Chopra (M)

The World Bank, Washington, District of Columbia, USA.

Simon Cousens (S)

London School of Hygiene and Tropical Medicine, London, UK.

Goran Krstić (G)

International Society of Global Health, Edinburgh, UK.

Calum Macdonald (C)

Centre for Global Health, Usher Institute, University of Edinburgh, UK.

Parisa Mansoori (P)

National Institute for Health Research, London, UK.

Smruti Patel (S)

Editor, Journal of Global Health Reports, Washington, DC, USA.

Aziz Sheikh (A)

Usher Institute, University of Edinburgh, Edinburgh, UK.

Mark Tomlinson (M)

Stellenbosch University, Cape Town, South Africa.

Alexander C Tsai (AC)

Massachusetts General Hospital, Boston, Massachusetts, USA.

Sachiyo Yoshida (S)

World Health Organization, Geneva, Switzerland.

Igor Rudan (I)

Centre for Global Health, Usher Institute, University of Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH